The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug of Abuse (DOA) Testing-Global Market Insights and Sales Trends 2025
Synopsis
The drug of abuse test is an immunoassay based on the principle of competitive binding.
The global Drug of Abuse (DOA) Testing market size is expected to reach US$ 9703.7 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drug of Abuse (DOA) Testing in various end use industries. The expanding demands from the Hospitals, Laboratories, Workplace and At-Home, are propelling Drug of Abuse (DOA) Testing market. Urine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Saliva segment is estimated at % CAGR for the next seven-year period.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug of Abuse (DOA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug of Abuse (DOA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug of Abuse (DOA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug of Abuse (DOA) Testing covered in this report include Siemens, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics and Psychemedics, etc.
The global Drug of Abuse (DOA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Global Drug of Abuse (DOA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug of Abuse (DOA) Testing market, Segment by Type:
Urine
Saliva
Hair
Others
Global Drug of Abuse (DOA) Testing market, by Application
Hospitals
Laboratories
Workplace
At-Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The drug of abuse test is an immunoassay based on the principle of competitive binding.
The global Drug of Abuse (DOA) Testing market size is expected to reach US$ 9703.7 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drug of Abuse (DOA) Testing in various end use industries. The expanding demands from the Hospitals, Laboratories, Workplace and At-Home, are propelling Drug of Abuse (DOA) Testing market. Urine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Saliva segment is estimated at % CAGR for the next seven-year period.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug of Abuse (DOA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug of Abuse (DOA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug of Abuse (DOA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug of Abuse (DOA) Testing covered in this report include Siemens, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics and Psychemedics, etc.
The global Drug of Abuse (DOA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Global Drug of Abuse (DOA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug of Abuse (DOA) Testing market, Segment by Type:
Urine
Saliva
Hair
Others
Global Drug of Abuse (DOA) Testing market, by Application
Hospitals
Laboratories
Workplace
At-Home
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug of Abuse (DOA) Testing
1.1 Drug of Abuse (DOA) Testing Market Overview
1.1.1 Drug of Abuse (DOA) Testing Product Scope
1.1.2 Drug of Abuse (DOA) Testing Market Status and Outlook
1.2 Global Drug of Abuse (DOA) Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug of Abuse (DOA) Testing Market Size by Region (2018-2029)
1.4 Global Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
1.5 Global Drug of Abuse (DOA) Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.1 North America Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.2 Europe Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.4 Latin America Drug of Abuse (DOA) Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2018-2029)
2 Drug of Abuse (DOA) Testing Market by Type
2.1 Introduction
2.1.1 Urine
2.1.2 Saliva
2.1.3 Hair
2.1.4 Others
2.2 Global Drug of Abuse (DOA) Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2029)
3 Drug of Abuse (DOA) Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratories
3.1.3 Workplace
3.1.4 At-Home
3.1.5 Others
3.2 Global Drug of Abuse (DOA) Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2029)
4 Drug of Abuse (DOA) Testing Competition Analysis by Players
4.1 Global Drug of Abuse (DOA) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2022)
4.3 Date of Key Players Enter into Drug of Abuse (DOA) Testing Market
4.4 Global Top Players Drug of Abuse (DOA) Testing Headquarters and Area Served
4.5 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Drug of Abuse (DOA) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens
5.1.1 Siemens Profile
5.1.2 Siemens Main Business
5.1.3 Siemens Drug of Abuse (DOA) Testing Products, Services and Solutions
5.1.4 Siemens Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Drug of Abuse (DOA) Testing Products, Services and Solutions
5.2.4 Merck Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Drug of Abuse (DOA) Testing Products, Services and Solutions
5.3.4 Roche Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Drug of Abuse (DOA) Testing Products, Services and Solutions
5.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Drug of Abuse (DOA) Testing Products, Services and Solutions
5.6.4 Abbott Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Quest Diagnostics
5.7.1 Quest Diagnostics Profile
5.7.2 Quest Diagnostics Main Business
5.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Products, Services and Solutions
5.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Quest Diagnostics Recent Developments
5.8 Psychemedics
5.8.1 Psychemedics Profile
5.8.2 Psychemedics Main Business
5.8.3 Psychemedics Drug of Abuse (DOA) Testing Products, Services and Solutions
5.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Psychemedics Recent Developments
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug of Abuse (DOA) Testing Market Dynamics
11.1 Drug of Abuse (DOA) Testing Industry Trends
11.2 Drug of Abuse (DOA) Testing Market Drivers
11.3 Drug of Abuse (DOA) Testing Market Challenges
11.4 Drug of Abuse (DOA) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
